Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...
The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Business Today1d
Glenmark Pharmaceuticals Ltd (GLENMARK) Share Price
Glenmark Pharmaceuticals Ltd share price was up by 0.49% from the previous closing price of ₹1,486.70. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...
Le Lézard18h
AI and Automation Software Market to Hit $86 Billion in 2024 - 24% CAGR Expected in Coming Years | Valuates Reports
AI and Automation Software Market is Segmented by Type (Marketing Automation, Manufacturing Automation, Business Automation), by Application (Industry, ...
FiercePharma3d
Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues
A trio of drugmakers have issued separate recalls in the U.S. thanks to string of production flubs, including failed impurity and dissolution specifications and incorrect labelling of infusion bags.
EquityBulls2d
ConfirmTkt Renews Partnership with Royal Challengers Bengaluru as the Official Train Ticketing Partner for T20 Season 2025
ConfirmTkt, India's leading online train-utility and ticketing platform, has renewed its association with Royal Challengers ...
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
Business Insider4d
China SXT Pharmaceuticals regains compliance with Nasdaq
China SXT Pharmaceuticals (SXTC) announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market dated March 13, 2025, informing ...
News Medical3d
Biomanufacturing platform offers a sustainable alternative to synthesizing peptide-based pharmaceuticals
It offers a sustainable - and affordable – alternative to synthesizing important peptide-based pharmaceuticals, thanks to a plant-based production system known as biopharming. The project ...
Benzinga.com3d
Recursion Pharmaceuticals's Options: A Look at What the Big Money is Thinking
Investors with a lot of money to spend have taken a bearish stance on Recursion Pharmaceuticals RXRX. And retail traders should know. We noticed this today when the positions showed up on publicly ...
News Medical3d
The CDMO Surge: Why Pharma Is Outsourcing More Than Ever
It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all sizes. Federal regulations like the Current Good Manufacturing ...